Skip to content
Peptigraph home
Shop Peptides50% off*

Semaglutide for Eyes: What the Evidence Shows

What human and animal studies show about Semaglutide for eyes, how strong that evidence is, and what is still unproven.

Medical review pendingGLP-1 agonistUpdated
Strongest evidence
None graded
no study with an outcome for eyes (PubMed search, 2 Oct 2026)
Human studies
None found
with an outcome for eyes, in our evidence file (PubMed search, 2 Oct 2026)
Animal studies
None found
with an outcome for eyes, in our evidence file (PubMed search, 2 Oct 2026)

Evidence for eyes

None of the study abstracts we summarised for Semaglutide reported an outcome for eyes (PubMed search, 2 Oct 2026). Claims that it helps with eyes are unproven.

How strong is it?

Strongest evidence:No graded study for eyes (PubMed search, 2 Oct 2026)

A human randomized trial outweighs any number of animal studies. Animal and cell results show a mechanism worth testing, not that it works in people.

MedlinePlus background on eyes

MedlinePlus defines eye care as keeping the eyes healthy through daily habits, regular checkups and treatment when needed, which is the baseline for reading the semaglutide studies below.[12]

What the semaglutide research on eyes actually reports

A PubMed title-and-abstract search pairing semaglutide terms with eyes terms, run on 29 Oct 2026, matched 219 records; the count measures how much has been written, not what it found.

Calculated from pubmed query (semaglutide[tiab] OR Ozempic[tiab] OR Wegovy[tiab] OR Rybelsus[tiab] OR NN9535[tiab]) AND (eye[tiab] OR eyes[tiab] OR ocular[tiab] OR ophthalm*[tiab] OR retina[tiab] OR retinal[tiab] OR retinopathy[tiab] OR cornea[tiab] OR corneal[tiab] OR glaucoma[tiab] OR vision[tiab]); date 2026-10-29; record count 219. Formula: number of PubMed records matching the query on the date shown, as recorded by the ledger run in research/keywords/expansion-2026-10/build/ledger-results.json

In pooled safety data from trials in type 2 diabetes, diabetic retinopathy incidence was higher with injected semaglutide than placebo in one trial, SUSTAIN 6.[13]

A review of semaglutide for obesity lists diabetic retinopathy among the other adverse events that have been reported.[14]

Limits to keep in mind for semaglutide and eyes

A dedicated safety review includes diabetic retinopathy complications in the list of adverse-event topics it examines for semaglutide.[15]

Other peptides people research for eyes

TB-500KLOWGLOWWolverineEpitalon
All peptides for eyes, compared

Common questions

Does Semaglutide help with eyes?

None of the studies we summarised for Semaglutide (PubMed search, 2 Oct 2026) measured an outcome for eyes. Treat claims that it helps with eyes as unproven.

Is Semaglutide approved for eyes?

Semaglutide is FDA approved (Ozempic, Wegovy, Rybelsus). Which conditions that approval covers is set by the label; use for anything else is off-label.

What is the best peptide for eyes?

There is no single answer. Our eyes overview compares each candidate by evidence grade and legal status rather than by popularity.

How does MedlinePlus describe eyes?

The National Library of Medicine's MedlinePlus gives this plain-language description of eyes, the condition behind the semaglutide question.[12]

Is there published research on semaglutide and eyes?

A PubMed search on 29 Oct 2026 pairing semaglutide terms with eyes terms matched 219 records, which says research exists in the literature and not that semaglutide has any effect on eyes.

Calculated from pubmed query (semaglutide[tiab] OR Ozempic[tiab] OR Wegovy[tiab] OR Rybelsus[tiab] OR NN9535[tiab]) AND (eye[tiab] OR eyes[tiab] OR ocular[tiab] OR ophthalm*[tiab] OR retina[tiab] OR retinal[tiab] OR retinopathy[tiab] OR cornea[tiab] OR corneal[tiab] OR glaucoma[tiab] OR vision[tiab]); date 2026-10-29; record count 219. Formula: number of PubMed records matching the query on the date shown, as recorded by the ledger run in research/keywords/expansion-2026-10/build/ledger-results.json

More on Semaglutide

DosageDoses used in published studies, with the source for each.CalculatorVial, water and dose to syringe units.Side effectsWhat labels and studies report, and what is unknown.BenefitsClaimed benefits next to what published studies measured.How it worksTarget, mechanism and how long it acts, from the label or studies.OralStudies that gave Semaglutide as pills and capsules, and what is approved.

Sources

  1. 1PubMed search: semaglutide[ti] AND (STEP OR "once-weekly semaglutide in adults with overweight or obesity" OR "Semaglutide 2.4 mg") AND randomized controlled trial[pt] (136 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
  2. 2PubMed search: semaglutide[ti] AND (cardiovascular outcomes OR "SELECT" OR "SUSTAIN" OR "PIONEER 6" OR "myocardial infarction") (560 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
  3. 3PubMed search: semaglutide[ti] AND (kidney OR FLOW OR "steatohepatitis" OR ESSENCE OR "heart failure" OR "knee osteoarthritis" OR Alzheimer) (590 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
  4. 4PubMed search: semaglutide[tiab] AND (meta-analysis[pt] OR systematic review[pt]) AND (weight OR obesity OR cardiovascular OR HbA1c) (361 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
  5. 5PubMed search: semaglutide[tiab] AND (pharmacokinetic*[tiab] OR half-life[tiab]) AND humans[mh] (136 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
  6. 6PubMed search: semaglutide[ti] AND (chronic kidney disease OR "knee osteoarthritis") AND randomized controlled trial[pt] (27 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
  7. 7PubMed search: semaglutide[tiab] AND (depress*[ti] OR suicid*[ti] OR "psychiatric"[ti] OR Alzheimer*[ti] OR cognit*[ti]) (159 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
  8. 8PubMed search: semaglutide[tiab] AND (blood pressure[ti] OR lipid*[ti] OR cholesterol[ti] OR "visceral"[ti] OR "waist"[ti] OR "body composition"[ti]) (112 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
  9. 9PubMed search: semaglutide[tiab] AND (rheumatoid[tiab] OR "psoriatic"[tiab] OR "inflammation"[ti] OR "C-reactive"[ti]) (60 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
  10. 10PubMed search: semaglutide[ti] AND ("knee osteoarthritis" OR "osteoarthritis" OR "obesity-related") AND (pain OR knee) (17 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
  11. 11PubMed search: semaglutide[tiab] AND (Alzheimer*[tiab] OR evoke[tiab]) AND (randomized controlled trial[pt] OR clinical trial[pt]) (3 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
  12. 12Official web pageOfficial web page · web page
  13. 13Safety and tolerability of semaglutide across the SUSTAIN and PIONEER phase IIIa clinical trial programmes.Diabetes, obesity & metabolism · 2023PMID 36700417Accessed 29 Oct 2026
  14. 14Semaglutide: a new drug for the treatment of obesity.Drug and therapeutics bulletin · 2023PMID 37879878Accessed 29 Oct 2026
  15. 15Safety of Semaglutide.Frontiers in endocrinology · 2021PMID 34305810Accessed 29 Oct 2026

Found an error? Report a correction.